Skin Mycobiome of Psoriasis Patients is Retained during Treatment with TNF and IL-17 Inhibitors

Skin Mycobiome of Psoriasis Patients is Retained during Treatment with TNF and IL-17 Inhibitors

Background: Biological treatment relieves refractory skin lesions in patients with psoriasis; however, changes in the fungal microbiome (the mycobiome) on the skin are unclear. Methods: The skin mycobiome of psoriasis patients treated with TNF inhibitors (TNFi, <i>n</i> = 5) and IL-17 in...

Full description

Bibliographic Details
Main Authors: Yuta Koike, Sayaka Kuwatsuka, Katsutaro Nishimoto, Daisuke Motooka, Hiroyuki Murota
Format: Article
Language:English
Published: MDPI AG 2020-05-01
Series:International Journal of Molecular Sciences
Subjects:
psoriasis
biologics
TNF inhibitor
IL-17 inhibitor
fungal microbiome
mycobiome
Online Access:https://www.mdpi.com/1422-0067/21/11/3892

Internet

https://www.mdpi.com/1422-0067/21/11/3892

Similar Items